Rebecca H. Williams

Mifepristone Litigation Update: Supreme Court Ruling On Standing Grounds Preserves The Status Quo Of FDA Regulation Of Mifepristone

A New Dawn For Challenges To FDA Actions? Kisor And The Tenuous Vitality Of Administrative Deference

The Latest FDA Move To Limit Digital Health Software Regs